Leading the Way in Advanced Therapies: A Fireside Chat on Act of Hope
Industry:
Biopharma, Cell and Gene Therapy
Type:
Video
Join Carol Houts, Chief Commercial Officer of Germfree, and Alexander Seyf (CEO of Autolomous) for an engaging fireside chat about ACT of Hope, the newly established scientific advisory board dedicated to advancing access to cell and gene therapies.
As key leaders and members of this initiative, Carol and Alexander will discuss the mission of ACT of Hope, its focus on addressing barriers to patient access, and how it fosters collaboration among industry leaders, clinical centers, and regulatory bodies.
This conversation will delve into the strategic goals of the advisory board, highlighting its emphasis on innovative manufacturing solutions, streamlined regulatory pathways, and equitable patient access. Carol and Alexander will also share their perspectives on the board’s early achievements, future objectives, and the transformative impact ACT of Hope is set to make in the field of advanced therapies.
You might also be interested in
Inside Germfree’s Isolator Engineering Process
Why Mobile and Modular Cleanrooms are Changing the Game in Bio-Manufacturing
Smarthood™: Setting a New Standard in IV Compounding
Contact us: Let's unlock your scientific potential together
Complete our contact form and a member of our commercial team will contact you within 24 hours.